APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Neurostimulators

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

Selected research

Industry Research

Implantable Neurostimulators Industry Research Report 2026

1 January 2026125 pages

Choose your research edition.

Industry ResearchImplantable Neurostimulators Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Neurostimulators Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Implantable Neurostimulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Neurostimulators Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Neurostimulators Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

The major players in United States Implantable Neurostimulators market include Medtronic, Boston Scientific, etc. The top 2 players occupy about 60% shares of the whole market. Mid-Atlantic Region and South Atlantic are main markets, they occupy about 40% of the whole market. Spinal Cord Stimulators is the main type, with a share about 55%. Pain is the main application, which holds a share about 55%.

Report Scope

Read the full market overview

This report quantifies the global Implantable Neurostimulators market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Implantable Neurostimulators Market by Company

Medtronic

Boston Scientific

St. Jude Medical

Cyberonics

NeuroPace

Synapse Biomedical

NeuroSigma

ReShape Lifesciences

ElectroCore Medical

Inspire Medical

NEUROS

SPR

IMTHERA

NEVRO

Implantable Neurostimulators Segment by Type

Deep Brain Stimulators

Spinal Cord Stimulators

Vagal Nerve Stimulators

Sacral Nerve Stimulators

Gastric Stimulators

Others

Implantable Neurostimulators Segment by Application

Parkinson's Disease

Epilepsy

Pain

Others

Implantable Neurostimulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Implantable Neurostimulators by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Implantable Neurostimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Implantable Neurostimulators Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Implantable Neurostimulators Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Implantable Neurostimulators Sales Market Share by Manufacturers (2021-2026) Table 8. Global Implantable Neurostimulators Revenue of Manufacturers (2021-2026) Table 9. Global Implantable Neurostimulators Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Implantable Neurostimulators Average Price (K US$/Unit) of Manufacturers (2021-2026) Table 11. Global Implantable Neurostimulators Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Implantable Neurostimulators, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Implantable Neurostimulators, Product Type & Application Table 14. Global Implantable Neurostimulators Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Implantable Neurostimulators by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Medtronic Company Information Table 19. Medtronic Business Overview Table 20. Medtronic Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 21. Medtronic Implantable Neurostimulators Product Portfolio Table 22. Medtronic Recent Developments Table 23. Boston Scientific Company Information Table 24. Boston Scientific Business Overview Table 25. Boston Scientific Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 26. Boston Scientific Implantable Neurostimulators Product Portfolio Table 27. Boston Scientific Recent Developments Table 28. St. Jude Medical Company Information Table 29. St. Jude Medical Business Overview Table 30. St. Jude Medical Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 31. St. Jude Medical Implantable Neurostimulators Product Portfolio Table 32. St. Jude Medical Recent Developments Table 33. Cyberonics Company Information Table 34. Cyberonics Business Overview Table 35. Cyberonics Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 36. Cyberonics Implantable Neurostimulators Product Portfolio Table 37. Cyberonics Recent Developments Table 38. NeuroPace Company Information Table 39. NeuroPace Business Overview Table 40. NeuroPace Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 41. NeuroPace Implantable Neurostimulators Product Portfolio Table 42. NeuroPace Recent Developments Table 43. Synapse Biomedical Company Information Table 44. Synapse Biomedical Business Overview Table 45. Synapse Biomedical Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 46. Synapse Biomedical Implantable Neurostimulators Product Portfolio Table 47. Synapse Biomedical Recent Developments Table 48. NeuroSigma Company Information Table 49. NeuroSigma Business Overview Table 50. NeuroSigma Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 51. NeuroSigma Implantable Neurostimulators Product Portfolio Table 52. NeuroSigma Recent Developments Table 53. ReShape Lifesciences Company Information Table 54. ReShape Lifesciences Business Overview Table 55. ReShape Lifesciences Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 56. ReShape Lifesciences Implantable Neurostimulators Product Portfolio Table 57. ReShape Lifesciences Recent Developments Table 58. ElectroCore Medical Company Information Table 59. ElectroCore Medical Business Overview Table 60. ElectroCore Medical Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 61. ElectroCore Medical Implantable Neurostimulators Product Portfolio Table 62. ElectroCore Medical Recent Developments Table 63. Inspire Medical Company Information Table 64. Inspire Medical Business Overview Table 65. Inspire Medical Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 66. Inspire Medical Implantable Neurostimulators Product Portfolio Table 67. Inspire Medical Recent Developments Table 68. NEUROS Company Information Table 69. NEUROS Business Overview Table 70. NEUROS Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 71. NEUROS Implantable Neurostimulators Product Portfolio Table 72. NEUROS Recent Developments Table 73. SPR Company Information Table 74. SPR Business Overview Table 75. SPR Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 76. SPR Implantable Neurostimulators Product Portfolio Table 77. SPR Recent Developments Table 78. IMTHERA Company Information Table 79. IMTHERA Business Overview Table 80. IMTHERA Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 81. IMTHERA Implantable Neurostimulators Product Portfolio Table 82. IMTHERA Recent Developments Table 83. NEVRO Company Information Table 84. NEVRO Business Overview Table 85. NEVRO Implantable Neurostimulators Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 86. NEVRO Implantable Neurostimulators Product Portfolio Table 87. NEVRO Recent Developments Table 88. Global Implantable Neurostimulators Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Implantable Neurostimulators Sales by Region (2021-2026) & (K Units) Table 90. Global Implantable Neurostimulators Sales Market Share by Region (2021-2026) Table 91. Global Implantable Neurostimulators Sales by Region (2027-2032) & (K Units) Table 92. Global Implantable Neurostimulators Sales Market Share by Region (2027-2032) Table 93. Global Implantable Neurostimulators Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Implantable Neurostimulators Revenue Market Share by Region (2021-2026) Table 95. Global Implantable Neurostimulators Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Implantable Neurostimulators Revenue Market Share by Region (2027-2032) Table 97. North America Implantable Neurostimulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 99. North America Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 100. North America Implantable Neurostimulators Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Implantable Neurostimulators Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Implantable Neurostimulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 104. Europe Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 105. Europe Implantable Neurostimulators Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Implantable Neurostimulators Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Implantable Neurostimulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Implantable Neurostimulators Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Implantable Neurostimulators Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Implantable Neurostimulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 114. South America Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 115. South America Implantable Neurostimulators Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Implantable Neurostimulators Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Implantable Neurostimulators Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Implantable Neurostimulators Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Implantable Neurostimulators Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Implantable Neurostimulators Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Implantable Neurostimulators Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Implantable Neurostimulators Sales by Type (2021-2026) & (K Units) Table 123. Global Implantable Neurostimulators Sales by Type (2027-2032) & (K Units) Table 124. Global Implantable Neurostimulators Sales Market Share by Type (2021-2026) Table 125. Global Implantable Neurostimulators Sales Market Share by Type (2027-2032) Table 126. Global Implantable Neurostimulators Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Implantable Neurostimulators Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Implantable Neurostimulators Revenue Market Share by Type (2021-2026) Table 129. Global Implantable Neurostimulators Revenue Market Share by Type (2027-2032) Table 130. Global Implantable Neurostimulators Price by Type (2021-2026) & (K US$/Unit) Table 131. Global Implantable Neurostimulators Price by Type (2027-2032) & (K US$/Unit) Table 132. Global Implantable Neurostimulators Sales by Application (2021-2026) & (K Units) Table 133. Global Implantable Neurostimulators Sales by Application (2027-2032) & (K Units) Table 134. Global Implantable Neurostimulators Sales Market Share by Application (2021-2026) Table 135. Global Implantable Neurostimulators Sales Market Share by Application (2027-2032) Table 136. Global Implantable Neurostimulators Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Implantable Neurostimulators Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Implantable Neurostimulators Revenue Market Share by Application (2021-2026) Table 139. Global Implantable Neurostimulators Revenue Market Share by Application (2027-2032) Table 140. Global Implantable Neurostimulators Price by Application (2021-2026) & (K US$/Unit) Table 141. Global Implantable Neurostimulators Price by Application (2027-2032) & (K US$/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Implantable Neurostimulators Distributors List Table 145. Implantable Neurostimulators Customers List Table 146. Implantable Neurostimulators Industry Trends Table 147. Implantable Neurostimulators Industry Drivers Table 148. Implantable Neurostimulators Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Implantable Neurostimulators Product Image Figure 5. Global Implantable Neurostimulators Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Implantable Neurostimulators Market Size (2021-2032) & (US$ Million) Figure 7. Global Implantable Neurostimulators Sales (2021-2032) & (K Units) Figure 8. Global Implantable Neurostimulators Average Price (K US$/Unit) & (2021-2032) Figure 9. Deep Brain Stimulators Product Image Figure 10. Spinal Cord Stimulators Product Image Figure 11. Vagal Nerve Stimulators Product Image Figure 12. Sacral Nerve Stimulators Product Image Figure 13. Gastric Stimulators Product Image Figure 14. Others Product Image Figure 15. Parkinson's Disease Product Image Figure 16. Epilepsy Product Image Figure 17. Pain Product Image Figure 18. Others Product Image Figure 19. Global Implantable Neurostimulators Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Implantable Neurostimulators, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Implantable Neurostimulators Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Implantable Neurostimulators Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Implantable Neurostimulators Sales by Region in 2025 Figure 25. Global Implantable Neurostimulators Revenue by Region in 2025 Figure 26. North America Implantable Neurostimulators Market Size by Country in 2025 Figure 27. North America Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 28. North America Implantable Neurostimulators Revenue Market Share by Country (2021-2032) Figure 29. United States Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Implantable Neurostimulators Market Size by Country in 2025 Figure 33. Europe Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 34. Europe Implantable Neurostimulators Revenue Market Share by Country (2021-2032) Figure 35. Germany Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Implantable Neurostimulators Market Size by Country in 2025 Figure 46. Asia Pacific Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Implantable Neurostimulators Revenue Market Share by Country (2021-2032) Figure 48. China Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Implantable Neurostimulators Market Size by Country in 2025 Figure 57. South America Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 58. South America Implantable Neurostimulators Revenue Market Share by Country (2021-2032) Figure 59. Brazil Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Implantable Neurostimulators Market Size by Country in 2025 Figure 63. Middle East and Africa Implantable Neurostimulators Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Implantable Neurostimulators Revenue Market Share by Country (2021-2032) Figure 65. Egypt Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Implantable Neurostimulators Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Implantable Neurostimulators Sales Market Share by Type (2021-2032) Figure 71. Global Implantable Neurostimulators Revenue Market Share by Type (2021-2032) Figure 72. Global Implantable Neurostimulators Price (K US$/Unit) by Type (2021-2032) Figure 73. Global Implantable Neurostimulators Sales Market Share by Application (2021-2032) Figure 74. Global Implantable Neurostimulators Revenue Market Share by Application (2021-2032) Figure 75. Global Implantable Neurostimulators Price (K US$/Unit) by Application (2021-2032) Figure 76. Implantable Neurostimulators Value Chain Figure 77. Implantable Neurostimulators Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Implantable Neurostimulators Industry Opportunities and Challenges

Scope & coverage.

Types
  • Deep Brain Stimulators
  • Spinal Cord Stimulators
  • Vagal Nerve Stimulators
  • Sacral Nerve Stimulators
  • Gastric Stimulators
  • Others
Applications
  • Parkinson's Disease
  • Epilepsy
  • Pain
  • Others
Companies covered
  • Medtronic
  • Boston Scientific
  • St. Jude Medical
  • Cyberonics
  • NeuroPace
  • Synapse Biomedical
  • NeuroSigma
  • ReShape Lifesciences
  • ElectroCore Medical
  • Inspire Medical
  • NEUROS
  • SPR
  • IMTHERA
  • NEVRO

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Implantable Neurostimulators Market Size (2021-2032)
  4. 2.2.2 Global Implantable Neurostimulators Sales (2021-2032)
  5. 2.2.3 Global Implantable Neurostimulators Market Average Price (2021-2032)
  6. 2.3 Implantable Neurostimulators by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Deep Brain Stimulators
  9. 2.3.3 Spinal Cord Stimulators
  10. 2.3.4 Vagal Nerve Stimulators
  11. 2.3.5 Sacral Nerve Stimulators
  12. 2.3.6 Gastric Stimulators
  13. 2.3.7 Others
  14. 2.4 Implantable Neurostimulators by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Parkinson's Disease
  17. 2.4.3 Epilepsy
  18. 2.4.4 Pain
  19. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Implantable Neurostimulators Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Implantable Neurostimulators Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Implantable Neurostimulators Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Implantable Neurostimulators Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Implantable Neurostimulators Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Implantable Neurostimulators, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Implantable Neurostimulators, Product Type & Application
  8. 3.8 Global Manufacturers of Implantable Neurostimulators, Established Date
  9. 3.9 Global Implantable Neurostimulators Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Medtronic
  2. 4.1.1 Medtronic Company Information
  3. 4.1.2 Medtronic Business Overview
  4. 4.1.3 Medtronic Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Medtronic Implantable Neurostimulators Product Portfolio
  6. 4.1.5 Medtronic Recent Developments
  7. 4.2 Boston Scientific
  8. 4.2.1 Boston Scientific Company Information
  9. 4.2.2 Boston Scientific Business Overview
  10. 4.2.3 Boston Scientific Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Boston Scientific Implantable Neurostimulators Product Portfolio
  12. 4.2.5 Boston Scientific Recent Developments
  13. 4.3 St. Jude Medical
  14. 4.3.1 St. Jude Medical Company Information
  15. 4.3.2 St. Jude Medical Business Overview
  16. 4.3.3 St. Jude Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 St. Jude Medical Implantable Neurostimulators Product Portfolio
  18. 4.3.5 St. Jude Medical Recent Developments
  19. 4.4 Cyberonics
  20. 4.4.1 Cyberonics Company Information
  21. 4.4.2 Cyberonics Business Overview
  22. 4.4.3 Cyberonics Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Cyberonics Implantable Neurostimulators Product Portfolio
  24. 4.4.5 Cyberonics Recent Developments
  25. 4.5 NeuroPace
  26. 4.5.1 NeuroPace Company Information
  27. 4.5.2 NeuroPace Business Overview
  28. 4.5.3 NeuroPace Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 NeuroPace Implantable Neurostimulators Product Portfolio
  30. 4.5.5 NeuroPace Recent Developments
  31. 4.6 Synapse Biomedical
  32. 4.6.1 Synapse Biomedical Company Information
  33. 4.6.2 Synapse Biomedical Business Overview
  34. 4.6.3 Synapse Biomedical Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Synapse Biomedical Implantable Neurostimulators Product Portfolio
  36. 4.6.5 Synapse Biomedical Recent Developments
  37. 4.7 NeuroSigma
  38. 4.7.1 NeuroSigma Company Information
  39. 4.7.2 NeuroSigma Business Overview
  40. 4.7.3 NeuroSigma Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 NeuroSigma Implantable Neurostimulators Product Portfolio
  42. 4.7.5 NeuroSigma Recent Developments
  43. 4.8 ReShape Lifesciences
  44. 4.8.1 ReShape Lifesciences Company Information
  45. 4.8.2 ReShape Lifesciences Business Overview
  46. 4.8.3 ReShape Lifesciences Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 ReShape Lifesciences Implantable Neurostimulators Product Portfolio
  48. 4.8.5 ReShape Lifesciences Recent Developments
  49. 4.9 ElectroCore Medical
  50. 4.9.1 ElectroCore Medical Company Information
  51. 4.9.2 ElectroCore Medical Business Overview
  52. 4.9.3 ElectroCore Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 ElectroCore Medical Implantable Neurostimulators Product Portfolio
  54. 4.9.5 ElectroCore Medical Recent Developments
  55. 4.10 Inspire Medical
  56. 4.10.1 Inspire Medical Company Information
  57. 4.10.2 Inspire Medical Business Overview
  58. 4.10.3 Inspire Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Inspire Medical Implantable Neurostimulators Product Portfolio
  60. 4.10.5 Inspire Medical Recent Developments
  61. 4.11 NEUROS
  62. 4.11.1 NEUROS Company Information
  63. 4.11.2 NEUROS Business Overview
  64. 4.11.3 NEUROS Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 NEUROS Implantable Neurostimulators Product Portfolio
  66. 4.11.5 NEUROS Recent Developments
  67. 4.12 SPR
  68. 4.12.1 SPR Company Information
  69. 4.12.2 SPR Business Overview
  70. 4.12.3 SPR Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 SPR Implantable Neurostimulators Product Portfolio
  72. 4.12.5 SPR Recent Developments
  73. 4.13 IMTHERA
  74. 4.13.1 IMTHERA Company Information
  75. 4.13.2 IMTHERA Business Overview
  76. 4.13.3 IMTHERA Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 IMTHERA Implantable Neurostimulators Product Portfolio
  78. 4.13.5 IMTHERA Recent Developments
  79. 4.14 NEVRO
  80. 4.14.1 NEVRO Company Information
  81. 4.14.2 NEVRO Business Overview
  82. 4.14.3 NEVRO Implantable Neurostimulators Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 NEVRO Implantable Neurostimulators Product Portfolio
  84. 4.14.5 NEVRO Recent Developments
5 Global Implantable Neurostimulators Market Scenario by Region
  1. 5.1 Global Implantable Neurostimulators Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Implantable Neurostimulators Sales by Region: 2021-2032
  3. 5.2.1 Global Implantable Neurostimulators Sales by Region: 2021-2026
  4. 5.2.2 Global Implantable Neurostimulators Sales by Region: 2027-2032
  5. 5.3 Global Implantable Neurostimulators Revenue by Region: 2021-2032
  6. 5.3.1 Global Implantable Neurostimulators Revenue by Region: 2021-2026
  7. 5.3.2 Global Implantable Neurostimulators Revenue by Region: 2027-2032
  8. 5.4 North America Implantable Neurostimulators Market Facts & Figures by Country
  9. 5.4.1 North America Implantable Neurostimulators Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Implantable Neurostimulators Sales by Country (2021-2032)
  11. 5.4.3 North America Implantable Neurostimulators Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Implantable Neurostimulators Market Facts & Figures by Country
  16. 5.5.1 Europe Implantable Neurostimulators Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Implantable Neurostimulators Sales by Country (2021-2032)
  18. 5.5.3 Europe Implantable Neurostimulators Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Implantable Neurostimulators Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Implantable Neurostimulators Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Implantable Neurostimulators Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Implantable Neurostimulators Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Implantable Neurostimulators Market Facts & Figures by Country
  41. 5.7.1 South America Implantable Neurostimulators Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Implantable Neurostimulators Sales by Country (2021-2032)
  43. 5.7.3 South America Implantable Neurostimulators Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Implantable Neurostimulators Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Implantable Neurostimulators Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Implantable Neurostimulators Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Implantable Neurostimulators Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Implantable Neurostimulators Sales by Type (2021-2032)
  2. 6.1.1 Global Implantable Neurostimulators Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Implantable Neurostimulators Sales Market Share by Type (2021-2032)
  4. 6.2 Global Implantable Neurostimulators Revenue by Type (2021-2032)
  5. 6.2.1 Global Implantable Neurostimulators Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Implantable Neurostimulators Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Implantable Neurostimulators Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Implantable Neurostimulators Sales by Application (2021-2032)
  2. 7.1.1 Global Implantable Neurostimulators Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Implantable Neurostimulators Sales Market Share by Application (2021-2032)
  4. 7.2 Global Implantable Neurostimulators Revenue by Application (2021-2032)
  5. 7.2.1 Global Implantable Neurostimulators Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Implantable Neurostimulators Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Implantable Neurostimulators Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Implantable Neurostimulators Value Chain Analysis
  2. 8.1.1 Implantable Neurostimulators Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Implantable Neurostimulators Production Mode & Process
  5. 8.2 Implantable Neurostimulators Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Implantable Neurostimulators Distributors
  8. 8.2.3 Implantable Neurostimulators Customers
9 Global Implantable Neurostimulators Analyzing Market Dynamics
  1. 9.1 Implantable Neurostimulators Industry Trends
  2. 9.2 Implantable Neurostimulators Industry Drivers
  3. 9.3 Implantable Neurostimulators Industry Opportunities and Challenges
  4. 9.4 Implantable Neurostimulators Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst